Our Pricing

Buy Wegovy Online UK - Private Prescription Service

Published on: June 03, 2026

When you buy Wegovy online UK private prescription services through Cured Pharmacy, you access genuine UK-licensed semaglutide injections from £79.00, with transparent upfront pricing and a free clinical consultation that takes under three minutes. Our UK-registered prescribers assess your suitability and issue private prescriptions for same-day dispatch when clinically appropriate.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics a natural gut hormone that regulates appetite and food intake, reducing hunger signals sent to the brain and slowing gastric emptying to promote earlier satiety.

In the landmark STEP 1 trial, participants using once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results established semaglutide as one of the most effective pharmacological interventions for weight management currently available in the UK, with sustained weight loss maintained throughout the trial period when combined with lifestyle modifications.

Wegovy Dosing Schedule and Administration

Gradual Dose Escalation Protocol

Wegovy follows a structured dose escalation over 16-20 weeks to minimise gastrointestinal side effects [2]. You begin with 0.25mg once weekly for four weeks, then increase monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly. This gradual titration allows your body to adapt to the medication and significantly reduces the incidence of nausea and vomiting reported in clinical trials.

Each pre-filled pen is administered subcutaneously in the abdomen, thigh, or upper arm on the same day each week. Our pharmacist team provides detailed injection technique guidance with your first prescription, and you can rotate injection sites to prevent lipodystrophy. If you miss a dose by more than five days, clinical protocols recommend resuming at the previous tolerated dose level rather than continuing at the higher strength.

Private Prescription Process at Cured Pharmacy

Our online consultation takes under three minutes and collects your medical history, current medications, and weight management goals. A UK-registered prescriber from our clinical team reviews every assessment individually—there are no automated approvals. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical governance to ensure patient safety remains paramount.

If your prescriber determines Wegovy is clinically appropriate, we dispense genuine UK-licensed pens and arrange discreet delivery to your preferred address. Prices are displayed upfront before you start the consultation: Wegovy is available from £79.00, with no hidden fees or subscription traps. Follow-up prescriptions require a brief review consultation to monitor your progress and adjust dosing if needed, ensuring ongoing clinical oversight throughout your treatment journey.

Wegovy Compared to Other Weight Loss Treatments

Semaglutide vs Tirzepatide Mechanisms

While Wegovy activates GLP-1 receptors exclusively, newer dual-agonist treatments target both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) pathways. Head-to-head trial data suggests dual-agonist therapies may produce greater absolute weight reduction, though both medication classes require the same commitment to dietary modification and increased physical activity [3].

Your prescriber will consider your medical history, previous weight loss attempts, contraindications, and treatment preferences when recommending the most suitable option. Factors including injection frequency tolerance, side effect profiles, and existing metabolic conditions all influence the clinical decision. Both semaglutide and alternative GLP-1 therapies remain prescription-only medications requiring ongoing medical supervision.

Common Side Effects and Safety Monitoring

The most frequently reported adverse effects with Wegovy are gastrointestinal: nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [2]. These symptoms typically emerge during dose escalation and diminish over subsequent weeks as tolerance develops. Eating smaller portions, avoiding high-fat meals, and staying well-hydrated can help manage these effects during the initial treatment phase.

Serious but rare risks include pancreatitis, gallbladder disease, and thyroid C-cell tumours observed in rodent studies (though not conclusively demonstrated in humans) [2]. Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your prescriber will screen for these contraindications during your clinical assessment and provide guidance on warning signs that warrant immediate medical attention, such as severe persistent abdominal pain or unexplained neck lumps.

Maximising Weight Loss Results with Wegovy

Lifestyle Modifications That Enhance Outcomes

Clinical trial participants who achieved the greatest weight reductions combined semaglutide with reduced-calorie diets and increased physical activity of at least 150 minutes weekly [1]. Wegovy is not a standalone solution—it works by making dietary adherence easier through appetite suppression and enhanced satiety signals. Patients who view the medication as one component of comprehensive lifestyle change consistently report better long-term outcomes.

Regular monitoring of body weight, waist circumference, and metabolic markers helps track progress and identify any plateaus requiring intervention adjustment. Our clinical team recommends keeping a food diary during the first 12 weeks to identify eating patterns and emotional triggers. Behavioural support, whether through structured programmes or self-directed resources, significantly improves weight maintenance beyond the active treatment phase when you eventually discontinue the medication.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.